STOCK TITAN

QXO-PB Financials

QXO-PB
Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows QXO-PB (QXO-PB) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI QXO-PB FY2025

External funding, not operating scale, is carrying a business rebuild as investment spending outruns cash from current sales.

In FY2025 the company turned a -$279K net loss into $261K of operating cash flow, so reported losses were not the main use of cash. The heavier draw was capital deployment: $10.6M of investing outflow was mostly matched by $7.7M of financing, indicating the balance sheet is funding repositioning more than the present operation is.

The margin structure reset is the clearest operating change: gross margin fell from 39.7% in FY2023 to 23.0% in FY2025. FY2025 gross profit of $1.6M barely covered $1.4M of SG&A, leaving much less room to absorb overhead than the earlier business had.

The balance sheet looks liquid but newly leveraged: cash was $2.4M against $3.1M of long-term debt. The current ratio reached 3.6x, but compared with FY2024's debt-free posture, liquidity now depends more on recently raised capital and less on cash already in the business.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 45 / 100
Financial Profile 45/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of QXO-PB's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
0

QXO-PB has an operating margin of -3.6%, meaning the company retains $-4 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -124.8% the prior year.

Growth
0

QXO-PB's revenue surged 11925.0% year-over-year to $6.8M, reflecting rapid business expansion. This strong growth earns a score of 0/100.

Leverage
96

QXO-PB carries a low D/E ratio of 0.32, meaning only $0.32 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 96/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
70

With a current ratio of 3.58, QXO-PB holds $3.58 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 70/100.

Cash Flow
100

QXO-PB converts 2.7% of revenue into free cash flow ($183K). This strong cash generation earns a score of 100/100.

Returns
2

QXO-PB generates a -2.9% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 2/100. This is down from 0.5% the prior year.

Piotroski F-Score Weak
3/9

QXO-PB passes 3 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality Mixed
-0.94x

For every $1 of reported earnings, QXO-PB generates $-0.94 in operating cash flow ($261K OCF vs -$279K net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Interest Coverage At Risk
-1.4x

QXO-PB earns $-1.4 in operating income for every $1 of interest expense (-$245K vs $174K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$6.8M
YoY+11925.0%
5Y CAGR-30.2%
10Y CAGR-13.0%

QXO-PB generated $6.8M in revenue in fiscal year 2025. This represents an increase of 11925.0% from the prior year.

EBITDA
-$137K
YoY-93.2%

QXO-PB's EBITDA was -$137K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 93.2% from the prior year.

Net Income
-$279K
YoY-1097.9%

QXO-PB reported -$279K in net income in fiscal year 2025. This represents a decrease of 1097.9% from the prior year.

EPS (Diluted)
$-0.63
YoY-472.7%

QXO-PB earned $-0.63 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 472.7% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$183K
YoY+116.3%
5Y CAGR-35.2%
10Y CAGR+12.0%

QXO-PB generated $183K in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 116.3% from the prior year.

Cash & Debt
$2.4M
YoY-53.4%
5Y CAGR-18.6%
10Y CAGR+7.1%

QXO-PB held $2.4M in cash against $3.1M in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
675M
YoY+64.8%

QXO-PB had 675M shares outstanding in fiscal year 2025. This represents an increase of 64.8% from the prior year.

Margins & Returns

Gross Margin
23.0%
YoY-17.6pp
5Y CAGR-17.2pp
10Y CAGR-16.2pp

QXO-PB's gross margin was 23.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 17.6 percentage points from the prior year.

Operating Margin
-3.6%
YoY+121.2pp
5Y CAGR-4.1pp
10Y CAGR-4.9pp

QXO-PB's operating margin was -3.6% in fiscal year 2025, reflecting core business profitability. This is up 121.2 percentage points from the prior year.

Net Margin
-4.1%
YoY-53.3pp
5Y CAGR-4.5pp
10Y CAGR-5.4pp

QXO-PB's net profit margin was -4.1% in fiscal year 2025, showing the share of revenue converted to profit. This is down 53.3 percentage points from the prior year.

Return on Equity
-2.9%
YoY-3.4pp
5Y CAGR-5.3pp
10Y CAGR-26.9pp

QXO-PB's ROE was -2.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 3.4 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
$78K
YoY+76566.7%
5Y CAGR-8.9%
10Y CAGR+1.5%

QXO-PB invested $78K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 76566.7% from the prior year.

QXO-PB Income Statement

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Revenue N/A $2.7M+43.1% $1.9M-85.9% $13.5M N/A $13.1M-9.7% $14.5M+0.4% $14.4M
Cost of Revenue N/A $2.1M+39.1% $1.5M-81.5% $8.1M N/A $7.6M-12.6% $8.7M-0.9% $8.8M
Gross Profit N/A $636K+58.3% $402K-92.5% $5.4M N/A $5.5M-5.2% $5.8M+2.5% $5.7M
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses N/A $453K-0.9% $457K-99.0% $44.4M N/A $39.0M+298.0% $9.8M+88.8% $5.2M
Operating Income N/A $26K+115.9% -$162K+99.6% -$39.3M N/A -$33.7M-683.7% -$4.3M-1986.0% $228K
Interest Expense N/A $62K+18.7% $53K+775.0% $6K N/A $0 $0-100.0% $20K
Income Tax N/A $129K+172.5% -$178K-102.1% $8.5M N/A $6.1M+3150.0% -$200K-385.7% $70K
Net Income N/A -$139K-138.3% -$59K-100.7% $8.8M N/A $17.2M+2966.7% -$600K-534.8% $138K
EPS (Diluted) N/A $-0.24-60.0% $-0.15-400.0% $-0.03 N/A $-0.01+99.9% $-9.93 $0.21

QXO-PB Balance Sheet

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Total Assets $15.9B-4.5% $16.6B-2.8% $17.1B-99.7% $5.1T+100192.2% $5.1B-99.9% $5.1T+412.4% $988.2B+4637.5% $20.9B
Current Assets $5.5B+89136.2% $6.2M-4.3% $6.5M-99.9% $5.1B+0.3% $5.1B+0.7% $5.1B+416.0% $979.8M+7722.4% $12.5M
Cash & Equivalents $2.4B+102271.1% $2.3M+1.2% $2.3M-100.0% $5.1B+0.3% $5.1B+0.6% $5.0B+418.6% $971.3M+15367.4% $6.3M
Inventory $1.5B+89892.8% $1.7M-10.0% $1.8M N/A $0 N/A N/A N/A
Accounts Receivable $1.1B+73191.1% $1.6M-0.8% $1.6M-51.3% $3.2M+19.9% $2.7M+20.8% $2.2M-25.8% $3.0M+13.3% $2.7M
Goodwill $5.1B+100698.7% $5.1M-1.3% $5.1M+342.9% $1.2M-3.3% $1.2M+3.4% $1.2M+1.8% $1.1M0.0% $1.1M
Total Liabilities $6.2B-9.4% $6.8B-5.2% $7.2B-86.6% $53.8B+118362.6% $45.4M-99.8% $19.9B+17.3% $16.9B+27.9% $13.2B
Current Liabilities $1.6B+76097.0% $2.0M-6.1% $2.2M-96.0% $53.6M+18.8% $45.1M+130.7% $19.5M+23.4% $15.8M+32.4% $12.0M
Long-Term Debt $3.1B+0.1% $3.1B0.0% $3.1B N/A $0 $0-100.0% $693.0M-17.9% $843.7M
Total Equity $9.7B+98728.1% $9.8M-0.9% $9.9M-99.8% $5.1B+0.1% $5.1B+0.2% $5.0B+419.3% $971.2M+12678.9% $7.6M
Retained Earnings -$394.5M-143930.7% -$274K-163.1% -$104K+99.5% -$20.0M-222.2% -$6.2M-224.4% $5.0M+307.6% -$2.4M-32.7% -$1.8M

QXO-PB Cash Flow Statement

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Operating Cash Flow $186.6M+87711.8% $213K+222.0% -$174K-100.5% $36.5M-32.3% $53.9M+70.6% $31.6M+3067.1% -$1.1M-391.8% $365K
Capital Expenditures $28.4M+94252.2% $30K+53.9% $20K-86.6% $146K+7200.0% $2K $0-100.0% $39K-36.1% $61K
Free Cash Flow $158.2M+86632.5% $182K+194.1% -$194K-100.5% $36.4M-32.5% $53.9M+70.6% $31.6M+2962.3% -$1.1M-463.2% $304K
Investing Cash Flow -$25.9M-89210.3% -$29K+99.7% -$10.6M-1213.6% -$805K $0 $0+100.0% -$39K+36.1% -$61K
Financing Cash Flow -$105.8M-68114.1% -$155K-102.0% $7.9M+135.3% -$22.5M-0.1% -$22.5M-100.6% $4.0B+318.0% $966.1M+571738.5% -$169K
Dividends Paid $0 $0 N/A N/A $0 $0 N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

QXO-PB Financial Ratios

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Gross Margin N/A 23.3%+2.2pp 21.1%-18.8pp 39.9% N/A 42.0%+2.0pp 40.0%+0.8pp 39.2%
Operating Margin N/A 0.9%+9.4pp -8.5%+282.3pp -290.8% N/A -257.3%-227.6pp -29.7%-31.2pp 1.6%
Net Margin N/A -5.1%-2.0pp -3.1%-67.9pp 64.8% N/A 131.3%+135.4pp -4.1%-5.1pp 1.0%
Return on Equity N/A -1.4%-0.8pp -0.6%-0.8pp 0.2% N/A 0.3%+0.4pp -0.1%-1.9pp 1.8%
Return on Assets N/A 0.0%0.0pp 0.0%0.0pp 0.0% N/A 0.0%0.0pp -0.0%0.0pp 0.0%
Current Ratio 3.58+0.5 3.06+0.1 3.00-92.2 95.23-17.6 112.85-145.8 258.64+196.8 61.84+60.8 1.05
Debt-to-Equity 0.320.0 0.310.0 0.31+0.3 0.01+0.0 0.000.0 0.000.0 0.00-0.1 0.11
FCF Margin N/A 6.7%+16.8pp -10.2%-279.3pp 269.2% N/A 241.2%+248.8pp -7.6%-9.7pp 2.1%

Frequently Asked Questions

QXO-PB (QXO-PB) reported $6.8M in total revenue for fiscal year 2025. This represents a 11925.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

QXO-PB (QXO-PB) revenue grew by 11925% year-over-year, from $57K to $6.8M in fiscal year 2025.

No, QXO-PB (QXO-PB) reported a net income of -$279K in fiscal year 2025, with a net profit margin of -4.1%.

QXO-PB (QXO-PB) reported diluted earnings per share of $-0.63 for fiscal year 2025. This represents a -472.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

QXO-PB (QXO-PB) had EBITDA of -$137K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, QXO-PB (QXO-PB) had $2.4M in cash and equivalents against $3.1M in long-term debt.

QXO-PB (QXO-PB) had a gross margin of 23.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

QXO-PB (QXO-PB) had an operating margin of -3.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

QXO-PB (QXO-PB) had a net profit margin of -4.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

QXO-PB (QXO-PB) has a return on equity of -2.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

QXO-PB (QXO-PB) generated $183K in free cash flow during fiscal year 2025. This represents a 116.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

QXO-PB (QXO-PB) generated $261K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

QXO-PB (QXO-PB) had $15.9M in total assets as of fiscal year 2025, including both current and long-term assets.

QXO-PB (QXO-PB) invested $78K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

QXO-PB (QXO-PB) had 675M shares outstanding as of fiscal year 2025.

QXO-PB (QXO-PB) had a current ratio of 3.58 as of fiscal year 2025, which is generally considered healthy.

QXO-PB (QXO-PB) had a debt-to-equity ratio of 0.32 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

QXO-PB (QXO-PB) had a return on assets of -1.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

QXO-PB (QXO-PB) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

QXO-PB (QXO-PB) has an earnings quality ratio of -0.94x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

QXO-PB (QXO-PB) has an interest coverage ratio of -1.4x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

QXO-PB (QXO-PB) scores 45 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top